Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FWPAYNASDAQ:MGRXNASDAQ:TNXPNASDAQ:ZCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFWPAYForward Pharma A/S$300.00$424.38$1.43▼$5.33$6M-42.677 shs11 shsMGRXMangoceuticals$1.86-10.6%$1.91$1.32▼$7.66$10.75M2.75214,538 shs82,260 shsTNXPTonix Pharmaceuticals$32.79+1.3%$27.07$6.76▼$131.00$238.08M2.08932,739 shs519,279 shsZCMDZhongchao$1.25-15.0%$1.19$0.95▼$2.97$37.07M-0.03360,480 shs144,795 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFWPAYForward Pharma A/S0.00%0.00%0.00%0.00%0.00%MGRXMangoceuticals-10.58%-3.12%+10.06%-33.81%-97.57%TNXPTonix Pharmaceuticals+1.33%-11.31%+13.34%+10.14%-74.78%ZCMDZhongchao-14.97%+2.46%+8.70%-1.57%+3.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFWPAYForward Pharma A/SN/AN/AN/AN/AN/AN/AN/AN/AMGRXMangoceuticals0.3793 of 5 stars0.03.00.00.00.01.70.6TNXPTonix Pharmaceuticals2.8588 of 5 stars3.52.00.00.02.43.30.6ZCMDZhongchao0.2561 of 5 stars0.03.00.00.00.61.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFWPAYForward Pharma A/S 0.00N/AN/AN/AMGRXMangoceuticals 0.00N/AN/AN/ATNXPTonix Pharmaceuticals 3.00Buy$585.001,684.08% UpsideZCMDZhongchao 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ZCMD, MGRX, FWPAY, and TNXP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2025TNXPTonix PharmaceuticalsAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFWPAYForward Pharma A/SN/AN/AN/AN/AN/AN/AMGRXMangoceuticals$620K15.51N/AN/A$4.30 per share0.43TNXPTonix Pharmaceuticals$10.09M23.92N/AN/A$31.82 per share1.03ZCMDZhongchao$15.86M1.99N/AN/A$0.96 per share1.30Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFWPAYForward Pharma A/S-$1.89MN/A0.00∞N/AN/AN/AN/AN/AMGRXMangoceuticals-$8.71M-$4.64N/A∞N/A-2,191.76%-72.81%-66.58%8/13/2025 (Estimated)TNXPTonix Pharmaceuticals-$130.04M-$1,963.61N/AN/AN/A-1,313.87%-120.96%-101.28%8/15/2025 (Estimated)ZCMDZhongchao-$640KN/A0.00∞N/AN/AN/AN/AN/ALatest ZCMD, MGRX, FWPAY, and TNXP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025MGRXMangoceuticalsN/A-$1.29N/A-$1.29N/A$0.11 million5/12/2025Q1 2025TNXPTonix Pharmaceuticals-$3.23-$2.84+$0.39-$2.84$2.55 million$2.43 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFWPAYForward Pharma A/SN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/ATNXPTonix PharmaceuticalsN/AN/AN/AN/AN/AZCMDZhongchaoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFWPAYForward Pharma A/SN/AN/AN/AMGRXMangoceuticalsN/A0.120.12TNXPTonix PharmaceuticalsN/A12.3111.64ZCMDZhongchaoN/A12.2311.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFWPAYForward Pharma A/S2.63%MGRXMangoceuticals56.72%TNXPTonix Pharmaceuticals82.26%ZCMDZhongchao1.67%Insider OwnershipCompanyInsider OwnershipFWPAYForward Pharma A/S71.47%MGRXMangoceuticals16.00%TNXPTonix Pharmaceuticals0.03%ZCMDZhongchao28.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFWPAYForward Pharma A/SN/A20,0007,000Not OptionableMGRXMangoceuticals35.17 million4.34 millionNot OptionableTNXPTonix Pharmaceuticals507.36 million7.36 millionNot OptionableZCMDZhongchao14025.22 million18.00 millionNot OptionableZCMD, MGRX, FWPAY, and TNXP HeadlinesRecent News About These CompaniesWe're Keeping An Eye On Zhongchao's (NASDAQ:ZCMD) Cash Burn RateApril 27, 2025 | finance.yahoo.comZhongchao Inc. Expands Equity Base Through Private Placement and Warrant ExerciseDecember 13, 2024 | tipranks.comZhongchao Inc. Reports Mixed Financial Results for 2024November 2, 2024 | markets.businessinsider.comWhat's Going On With Zhongchao Stock Today?September 30, 2024 | msn.comWhy Is Scorpius (SCPX) Stock Down 79% Today?August 7, 2024 | msn.comWhy Is Zhongchao (ZCMD) Stock Up 52% Today?August 7, 2024 | investorplace.comZhongchao Inc. (ZCMD)July 19, 2024 | finance.yahoo.comZhongchao Full Year 2023 Earnings: US$4.35 loss per share (vs US$1.13 loss in FY 2022)May 3, 2024 | finance.yahoo.comWhy Is Zhongchao (ZCMD) Stock Up 103% Today?April 19, 2024 | investorplace.comZHONGCHAO Inc Ordinary Shares - Class AApril 16, 2024 | morningstar.comAltice USA, Genfit, Brooge Energy among premarket losers' packApril 5, 2024 | msn.comWhy Is Zhongchao (ZCMD) Stock Up 40% Today?April 4, 2024 | investorplace.comZhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of MedicationsMarch 12, 2024 | prnewswire.comWhy Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving PremarketMarch 5, 2024 | msn.comWhy Is Zhongchao (ZCMD) Stock Up 15% Today?March 5, 2024 | investorplace.comZhongchao Inc. Announces 1-for-10 Share ConsolidationFebruary 27, 2024 | prnewswire.comZhongchao First Half 2023 Earnings: US$0.18 loss per share (vs US$0.004 profit in 1H 2022)December 28, 2023 | finance.yahoo.comZhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer TreatmentsDecember 11, 2023 | finance.yahoo.comZhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness DayOctober 23, 2023 | finance.yahoo.comZhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer PatientsSeptember 25, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeZCMD, MGRX, FWPAY, and TNXP Company DescriptionsForward Pharma A/S NASDAQ:FWPAYForward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark.Mangoceuticals NASDAQ:MGRX$1.86 -0.22 (-10.58%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$1.76 -0.10 (-5.11%) As of 06/23/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.Tonix Pharmaceuticals NASDAQ:TNXP$32.79 +0.43 (+1.33%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$33.02 +0.23 (+0.72%) As of 06/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as rare disease, immunology, and infectious disease product candidates. The company's priority is to submit a New Drug Application (NDA) to the FDA for TNX-102 SL (cyclobenzaprine HCl sublingual tablet), which has completed two positive Phase 3 studies for the management of fibromyalgia. TNX-102 SL is also being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition. Its TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted breakthrough therapy designation by the FDA. The company's rare disease development portfolio comprises TNX-2900, an intranasal potentiated oxytocin for the treatment of Prader-Willi syndrome (PWS). Its immunology portfolio includes TNX-1500, which is a biologic to address organ transplant rejection and autoimmune diseases. The company's infectious disease pipeline includes TNX-801, a vaccine in development to prevent smallpox and mpox. TNX-801 also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases, including TNX-1800 and TNX-1850, in development as a vaccine to protect against COVID-19. Its infectious disease development portfolio also comprises TNX-3900, and TNX-4200 are orally available CD45 antagonists in preclinical development. Tonix Pharmaceuticals Holding Corp. has collaboration agreement with Bilthoven Biologicals to advance TNX-801 mpox vaccine candidate; and with X-Chem, Inc. to develop broad-spectrum antivirals. The company was founded in 2007 and is headquartered in Chatham, New Jersey.Zhongchao NASDAQ:ZCMD$1.25 -0.22 (-14.97%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$1.36 +0.11 (+9.12%) As of 06/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
